House Passes FDA User Fee Reauthorization Package

The House passed its version of the FDA user fee reauthorization package Wednesday that is expected to bring in $1.42 billion in fiscal 2018, by a voice vote.

The reauthorization package, H.R. 2430, saw strong, bipartisan support on the House floor leading up to its passage. The Senate’s version of the user fee bill is currently awaiting a vote. Afterwards, both houses must reconcile any differences between their texts before sending the bill for the president’s signature.

FDA Commissioner Scott Gottlieb said he was grateful for the House’s passage of the bill and specifically thanked the leaders of the House Energy and Commerce Committee, Reps. Greg Walden (R-Ore.) and Frank Pallone (D-N.J.).